Latest The Million Women Study Stories
A large study of US women suggests that obese women may have a higher risk of developing ovarian cancer than their thinner counterparts.
A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight.
PORTLAND, Ore., Oct. 31 /PRNewswire/ -- The art and science of hormone balancing vs. hormone replacement (HRT) is becoming the 'new normal' among many experts who believe that breast cancer and its risks can be prevented.
By DR. MIRIAM STOPPARD A million women in the UK have stopped taking hormone replacement therapy (HRT) thanks to scare stories based on flawed medical studies. New statistics show the number of prescriptions for HRT have fallen significantly.
By HILL, Ruth HORMONE replacement therapy could be "the female Viagra" for post- menopausal women, new research involving Wellington women suggests.
By THOMAS, Kim Post-menopausal women can get a libido boost by taking hormone replacement therapy (HRT), new research has found.
By Lyndsay Moss MEDICAL research can often produce conflicting advice on a number of health issues, making it difficult for women to know what to do for the best. In recent years, much concern has been raised over the safety of hormone replacement therapy (HRT).
British researchers reported yesterday that women who use birth control pills are protected against ovarian cancer for 30 years or longer after they stop taking the pills. They claim the pill has prevented at least 100,000 deaths.
By Foidart, Jean-Michel Faustmann, Thomas Abstract Hormone replacement therapy (HRT) remains the most effective treatment for menopausal symptom relief, and may provide cardiovascular benefits in younger women initiating treatment soon after menopause.
Myriad Genetics, Inc. (NASDAQ: MYGN) announced tod
- A gift; a largess; a gratuity; a present; a dole.